FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

372627001: Substance with chelating agent mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1211155012 Chelating agent en Synonym Active Entire term case insensitive SNOMED CT core module
3646144010 Substance with chelating agent mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3646150017 Substance with chelating agent mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module


25 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with chelating agent mechanism of action Is a Chelating agent / antidote false Inferred relationship Existential restriction modifier
Substance with chelating agent mechanism of action Is a Allergen class false Inferred relationship Existential restriction modifier
Substance with chelating agent mechanism of action Is a Drug allergen false Inferred relationship Existential restriction modifier
Substance with chelating agent mechanism of action Has disposition Chelating agent true Inferred relationship Existential restriction modifier
Substance with chelating agent mechanism of action Is a Substance categorized by disposition true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Uprima 3mg sublingual tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
APO-go 30mg/3mL prefilled pen Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Sodium calcium edetate bihydrate Is a True Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 2mg sublingual tablets (Abbott Laboratories Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 3mg sublingual tablets (Abbott Laboratories Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Nalorex 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture (Thornton & Ross Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
APO-go Pen 30mg/3ml solution for injection (Britannia Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
APO-go 20mg/2ml solution for injection ampoules (Britannia Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
APO-go 50mg/5ml solution for injection ampoules (Britannia Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Calcium Resonium powder (Sanofi-Synthelabo Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Renagel 800mg tablets (Genzyme Therapeutics) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Parvolex 2g/10ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Cystagon 150mg capsules (Recordati Rare Diseases UK Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Cystagon 50mg capsules (Recordati Rare Diseases UK Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets (The Boots Company) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Resonium A powder (Sanofi-Synthelabo Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Anexate 500micrograms/5ml solution for injection ampoules (Roche Products Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 50mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 50mg/5ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Prosulf 1% solution for injection 5ml ampoules (C P Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Minijet naloxone 400micrograms/1ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Narcan Neonatal 40micrograms/2ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Potassium iodate 85mg tablets (Cambridge Laboratories) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Minijet naloxone 800micrograms/2ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uromitexan 600mg tablets (Baxter Healthcare Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uromitexan 1g/10ml solution for injection ampoules (Baxter Healthcare Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uromitexan 400mg/4ml solution for injection ampoules (Baxter Healthcare Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 100mg/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 100mg/10ml solution for injection ampoules (Unichem Plc) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Digibind 38mg powder for solution for injection vials (GlaxoSmithKline) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Fasturtec 1.5mg powder and solvent for solution for infusion vials (Sanofi Genzyme) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Medicoal 5g effervescent granules sachets (Concord Pharmaceutical Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture (Unichem Plc) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets (Unichem Plc) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Activated charcoal biscuits Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ethylenediamine-N,N'-diacetic acid (EDDA) Is a True Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Flumazenil 500micrograms/5ml solution for injection ampoules (Pliva Pharma Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Acetylcysteine 2g/10ml solution for injection ampoules (Pliva Pharma Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Acetylcysteine 2g/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
J.L. Bragg's Medicinal Charcoal Biscuits (Bragg,J.L. Ltd) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Alum Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine powder Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
DL-Methionine powder (Societe Rexim) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine powder 5 kg Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
DL-Methionine powder (Societe Rexim) 5 kg Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mercaptamine hydrochloride powder Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Cysteamine hydrochloride powder (Synopharm GmbH & Co. KG) Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mercaptamine hydrochloride powder 100 gram Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Cysteamine hydrochloride powder (Synopharm GmbH & Co. KG) 100 gram Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 3mg sublingual tablets 2 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 2mg sublingual tablets 4 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 2mg sublingual tablets 2 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 3mg sublingual tablets 4 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Naltrexone 50mg tablets 28 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture 500 ml Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture 200 ml Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 30mg/3ml solution for injection pre-filled disposable devices 5 pre-filled disposable injection Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 20mg/2ml solution for injection ampoules 5 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Apomorphine 50mg/5ml solution for injection ampoules 5 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Calcium polystyrene sulphonate powder sugar free 300 gram Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Sevelamer 403mg capsules 200 capsule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Sevelamer 800mg tablets 180 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Acetylcysteine 2g/10ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mercaptamine 150mg capsules 100 capsule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mercaptamine 50mg capsules 100 capsule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets 250 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Methionine 250mg tablets 200 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Sodium polystyrene sulfonate powder sugar free 454 gram Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Flumazenil 500micrograms/5ml solution for injection ampoules 5 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 50mg/5ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Naloxone 400micrograms/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Naloxone 40micrograms/2ml solution for injection ampoules 10 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Razoxane 125mg tablets 30 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Potassium iodate 85mg tablets 100 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Naloxone 800micrograms/2ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mesna 600mg tablets 10 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mesna 400mg tablets 10 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mesna 1g/10ml solution for injection ampoules 15 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Mesna 400mg/4ml solution for injection ampoules 15 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 100mg/10ml solution for injection ampoules 5 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Protamine sulphate 100mg/10ml solution for injection ampoules 6 ampoule Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Digoxin-specific antibody fragments 38mg powder for solution for injection vials 1 vial Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Rasburicase 1.5mg powder and solvent for solution for injection vials 3 vial Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Activated charcoal 5g effervescent granules sachets 5 sachet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Potassium iodate 85mg tablets 10 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 2mg sublingual tablets (Abbott Laboratories Ltd) 2 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 2mg sublingual tablets (Abbott Laboratories Ltd) 4 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 3mg sublingual tablets (Abbott Laboratories Ltd) 2 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Uprima 3mg sublingual tablets (Abbott Laboratories Ltd) 4 tablet Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Nalorex 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 4 x 7 tablets Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture (A A H Pharmaceuticals Ltd) 500 ml Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier
Ammonia and Ipecacuanha mixture (A A H Pharmaceuticals Ltd) 200 ml Has active ingredient False Substance with chelating agent mechanism of action Inferred relationship Existential restriction modifier

Start Previous Page 4 of 5 End


This concept is not in any reference sets

Back to Start